Gymnema sylvestre
Ayurvedic gurmar ('sugar destroyer'), preliminary RCT signal for postprandial glucose and acute reduction of sweet taste perception.
Why
Gymnema sylvestre (gurmar, literally 'sugar destroyer' in Hindi) has been used in Ayurveda for over 2,000 years as a diabetes treatment. Standardised extracts (GS4) have small RCTs and open trials reporting reductions in fasting glucose, HbA1c, and insulin requirements in type 2 diabetes (Baskaran 1990, Shanmugasundaram 1990). The acute taste-modulation effect, suppression of sweet taste perception when leaf is chewed, is mechanistically interesting but unrelated to the systemic glycaemic effect.
How it works
Gymnemic acids reversibly bind sweet taste receptors (T1R2/T1R3), basis of the acute taste suppression. Systemic glycaemic effect via increased pancreatic insulin secretion and possible β-cell regeneration (preclinical data). Reduces intestinal glucose absorption.
Expected onset · Acute taste effect immediate; systemic glycaemic effects over 6–12 weeks
How to take
Dosage
Standardised extract (GS4, 25% gymnemic acids): 200 mg twice daily. Higher doses up to 500 mg three times daily used in trials.
Timing
Before main meals to blunt postprandial glucose
On the label
Standardised GS4 extract with stated gymnemic-acid content (25%) is the trial-grade form. Crude leaf or low-standardised extract is less consistent.
Ideal for
Adults with prediabetes or mild type 2 diabetes exploring Ayurvedic adjuncts; people seeking sweet-craving reduction.
Safety
Evidence
Baskaran 1990 open trial (n=22 type 2 diabetes): GS4 400 mg/day reduced HbA1c and fasting glucose over 18–20 months, with insulin reduction in some patients. Pothuraju 2014 systematic review noted directionally consistent results but limited modern RCT quality. Preliminary evidence, no Cochrane review, EMA HMPC monograph or EFSA-authorised health claim covers this indication; cited RCTs are small or in non-tier-1 journals. Useful as honest reference rather than evidence-grade recommendation.
Preliminary evidence, no Cochrane review, EMA HMPC monograph or EFSA-authorised health claim covers this indication; cited RCTs are small or in non-tier-1 journals. Useful as honest reference rather than evidence-grade recommendation.
- Baskaran et al., J Ethnopharmacol 1990, antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients
- Shanmugasundaram et al., J Ethnopharmacol 1990, use of Gymnema sylvestre leaf extract in the control of blood glucose in insulin-dependent diabetes mellitus
- Pothuraju et al., J Sci Food Agric 2014, a systematic review of Gymnema sylvestre in obesity and diabetes management
Where to get it
Shop Gymnema sylvestre on AmazonSponsored · As an Amazon Associate, Healicus earns from qualifying purchases.